Back
 OJRM  Vol.9 No.2 , June 2020
Design of Medical Devices Using Spongy Sheet Composed of Hyaluronic Acid and Collagen
Abstract: This research aims to obtain useful information for development of medical devices such as wound dressing and tissue anti-adhesive product, using a spongy sheet composed of hyaluronic acid (HA) and collagen (Col). The spongy sheets were manufactured by freeze vacuum drying of HA and Col aqueous solution, followed by UV irradiation to introduce intermolecular crosslinks between Col molecules. These spongy sheets are referred to as Sponge-A (ratio of HA/Col = 5/1) and Sponge-B (ratio of HA/Col = 5/5). Both surfaces of Sponge-A and Sponge-B treated with UV irradiation for 15 minutes are referred to as Sponge-A-15 and Sponge-B-15, respectively. The weight change of spongy sheet was determined by immersing a peace of spongy sheet in water at 37°C. The weight of sponge-A-15 collected 1/2, 1, 3, 7 days after immersion in water was 63.5%, 62.1%, 56.6%, 54.4% of the original weight, respectively. The weight of Sponge-B-15 was 78.3%, 76.7%, 79.1%, 71.9% of the original weight, respectively. The weight change of spongy sheet was determined by immersing a peace of spongy sheet in water containing collagenase at 37°C. The weight of Sponge-A-15 collected 6, 8, 10, 12 hours after immersion in water containing collagenase (0.0005 w/v%) was 65.7%, 59.8%, 57.9%, 55.2% of the original weight, respectively. The weight of Sponge-B-15 was 63.5%, 52.1%, 42.0%, 43.2% of the original weight, respectively. This spongy sheet is considered to have the unique structure, where HA molecules are entrapped in an intermolecular cross-linked network structure of Col molecules. When immersed in water containing collagenase, the weight loss of spongy sheet is accelerated by easy extraction of HA molecules from the enzymatic degraded Col network structure. The performance of wound dressing and tissue anti-adhesive product is considered to depend on appropriate ratio of HA and Col, and also on appropriate rate of intermolecular crosslinks between Col molecules. These findings obtained in this study provide useful information for product development such as wound dressing and tissue anti-adhesive product.
Cite this paper: Kuroyanagi, Y. , Ohno, H. , Suzuki, R. , Kuroyanagi, M. , Takeuchi, I. (2020) Design of Medical Devices Using Spongy Sheet Composed of Hyaluronic Acid and Collagen. Open Journal of Regenerative Medicine, 9, 71-84. doi: 10.4236/ojrm.2020.92008.
References

[1]   Kuroyanagi, Y. (2016) Tissue-Engineered Product for Skin Regenerative Medicine. Open Journal of Regenerative Medicine, 5, 61-84.
https://doi.org/10.4236/ojrm.2016.53006

[2]   Kuroyanagi, M. and Kuroyanagi, Y. (2017) Tissue-Engineered Products Capable of Enhancing Wound Healing. AIMS Materials Science, 4, 561-581.
https://doi.org/10.3934/matersci.2017.3.561

[3]   Kuroyanagi, M. and Kuroyanagi, Y. (2018) Advanced Treatment of Burns and Skin Ulcers Using Tissue-Engineered Products. Dermatology Case Reports, 3, 137-142.
https://doi.org/10.35248/2684-124X.18.3.137

[4]   Kuroyanagi, M. and Kuroyanagi, Y. (2018) Design Concept of Tissue-Engineered Products for Use in Emergency and Critical Care Medicine. Biomedical Journal of Science & Technology Research, 2, 692-694.
https://doi.org/10.26717/BJSTR.2018.02.000692

[5]   John Chen, W.Y. and Abatangelo, G. (1999) Functions of Hyaluronan in Wound Repair. Wound Repair and Regeneration, 7, 79-89.
https://doi.org/10.1046/j.1524-475X.1999.00079.x

[6]   Pardue, E.L., Ibrahim, S. and Ramamurthi, A. (2008) Role of Hyaluronan in Angiogenesis and Its Utility to Angiogenic Tissue Engineering. Organogenesis, 4, 203-214.
https://doi.org/10.4161/org.4.4.6926

[7]   Postlethwaite, A.E., Seyer, J.M. and Kang, A.H. (1978) Chemotactic Attraction of Human Fibroblasts to Type I, II, and III Collagens and Collagen-Derived Peptides. Proceedings of the National Academy of the Sciences of the United States of America, 78, 871-875.
https://doi.org/10.1073/pnas.75.2.871

[8]   Kondo, S. and Kuroyanagi, Y. (2011) Development of a Wound Dressing Composed of Hyaluronic Acid and Collagen Sponge with Epidermal Growth Factor. Journal of Biomaterials Science, Polymer Edition, 23, 629-643.
https://doi.org/10.1163/092050611X555687

[9]   Kondo, S., Niiyama, H., Yu, A. and Kuroyanagi, Y. (2012) Evaluation of a Wound Dressing Composed of Hyaluronic Acid and Collagen Sponge Containing Epidermal Growth Factor in Diabetic Mice. Journal of Biomaterials Science. Polymer Edition, 23, 1729-1740.
https://doi.org/10.1163/092050611X597799

[10]   Yu, A., Takeda, A., Kumazawa, K., Miyoshi, H., Kuroyanagi, M., Yoshitake, T., Uchinuma, E., Suzuki, R. and Kuroyanagi, Y. (2015) Preliminary Clinical Study Using a Novel Wound Dressing Composed of Hyaluronic Acid and Collagen Containing EGF. Open Journal Regenerative Medicine, 4, 6-13.
https://doi.org/10.4236/ojrm.2015.41002

[11]   Kuroyanagi, M., Yamamoto, A., Shimizu, N., Toi, A., Inomata, T., Takeda, A. and Kuroyanagi, Y. (2014) Development of Anti-Adhesive Spongy Sheet Composed of Hyaluronic Acid and Collagen Containing Epidermal Growth Factor. Journal of Biomaterials Science, Polymer Edition, 25, 1253-1265.
https://doi.org/10.1080/09205063.2014.926579

[12]   Carpenter, G. and Cohen, S. (1976) Human Epidermal Growth Factor and the Proliferation of Human Fibroblasts. Journal of Cell Physiology, 88, 227-237.
https://doi.org/10.1002/jcp.1040880212

[13]   Carpenter, G. and Cohen, S. (1979) Epidermal Growth Factor. Annual Review of Biochemistry, 48, 193-216.
https://doi.org/10.1146/annurev.bi.48.070179.001205

[14]   Buckley, A., Davidson, J.M., Kamerath, C.D., Wolt, T.B. and Woodward, S.C. (1985) Sustained Release of Epidermal Growth Factor Accelerates Wound Repair. Proceedings of the National Academy of Sciences of the United States of America, 82, 7340-7344.
https://doi.org/10.1073/pnas.82.21.7340

[15]   Yu, A., Matsuda, Y., Takeda, A., Uchinuma, E. and Kuroyanagi, Y. (2012) Effect of EGF and bFGF on Fibroblast Proliferation and Angiogenic Cytokine Production from Cultured Dermal Substitutes. Journal of Biomaterials Science, Polymer Edition, 23, 1315-1324.
https://doi.org/10.1163/092050611X580463

[16]   Bros, P. and Miller, C.M. (1995) Hepatocyte Growth Factor: A Multifunctional Cytokine. The Lancet, 345, 293-295.
https://doi.org/10.1016/S0140-6736(95)90279-1

[17]   Toyoda, M., Takayama, H., Horiguchi, N., Otsuka, T., Fulusato, T., Merlino, G., Takagi, H. and Mori, M. (2001) Overexpression of Hepatocyte Growth Factor/Scatter Factor Promotes Vascularization and Granulation Tissue Formation in Vivo. FEBS Letters, 509, 95-100.
https://doi.org/10.1016/S0014-5793(01)03126-X

[18]   Xin, X., Yang, S., Ingle, G., Zlot, C., Rangell, L., Kowalski, J., Schwall, R., Ferrara, N. and Gerritsen, M.E. (2001) Hepatocyte Growth Factor Enhances Vascular Endothelial Growth Fac-tor-Induce Angiogenesis in Vitro and in Vivo. The American Journal of Pathology, 158, 1111-1120.
https://doi.org/10.1016/S0002-9440(10)64058-8

[19]   Isago, Y., Suzuki, R., Isono, E., Noguchi, Y. and Kuroyanagi, Y. (2014) Development of a Freeze-Dried Skin Care Product Composed of Hyaluronic Acid and Poly(γ-Glutamic Acid) Containing Bioactive Components for Application after Chemical Peels. Open Journal of Regenerative Medicine, 3, 43-53.
https://doi.org/10.4236/ojrm.2014.33006

[20]   Yamamoto, A., Ohno, H. and Kuroyanagi, Y. (2016) Evaluation of Epidermal Growth Factor-Incorporating Skin Care Product in Culture Experiment Using Human Fibroblasts. Open Journal of Regenerative Medicine, 5, 44-54.
https://doi.org/10.4236/ojrm.2016.52004

 
 
Top